Early Life Thiamine Study
Early Life Thiamine Supplementation for Infant Neurocognitive Benefits: a Randomized Controlled Trial
1 other identifier
interventional
1,972
1 country
1
Brief Summary
Thiamine (vitamin B1) is an important nutrient needed for energy metabolism, brain development, and overall health. However, low thiamine intake is a concern in countries where white rice is the main staple since it contains little thiamine. If pregnant or breastfeeding women do not eat enough thiamine, their babies may also become deficient. Severe thiamine deficiency can cause beriberi, which can be life-threatening. Milder deficiency during early life may affect brain development. Healthy pregnant women should eat 1.4 mg thiamine daily. In a previous study in rural Cambodia, study investigators found that giving breastfeeding mothers a higher dose of thiamine (10mg per day) improved their infants' brain development at six months of age. However, supplementation began two weeks after birth. Since much of an infant's brain development occurs in utero, starting mother's supplementation earlier - in pregnancy - may provide greater benefits. Study investigators are now conducting a study with pregnant women in Cambodia. Participants will receive either the usual amount of thiamine found in multiple micronutrient supplements or a higher dose, beginning in pregnancy and continuing until their child is 18 months old. The primary outcome is cognition at 18 months, to see whether higher thiamine intake during pregnancy and early childhood leads to measurable improvements in early brain development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2026
CompletedFirst Submitted
Initial submission to the registry
August 19, 2026
CompletedFirst Posted
Study publicly available on registry
August 31, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 31, 2029
August 31, 2026
August 1, 2026
2.6 years
August 19, 2026
August 27, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mullen's Scales of Early Learning "Early Learning Composite" T-score (MSEL-ELC)
Early Learning Composite (ELC) Standard Score is derived from the sum of the age adjusted T-scores for all but the Gross Motor scales: ELC Standard Score = Visual Reception T-Score + Fine Motor T-Score + Receptive Language T-Score + Expressive Language T-Score ELC Standard Score Mean = 100 ELC Standard Score SD = 15 ELC Standard Score Range (Min/Max) = 49 to 155
18 months postnatal
Other Outcomes (6)
Mullen's Scales of Early Learning "Early Learning Composite" T-score (MSEL-ELC)
2 weeks and 6 months postnatal
Mullen's Scales of Early Learning sub-scales
2 weeks, 6 months, and 18 months postnatal
Global Scales of Early Development (GSED)
2 weeks, 6 months, and 18 months postnatal
- +3 more other outcomes
Study Arms (2)
Standard of Care +
PLACEBO COMPARATORmultiple micronutrient supplement formulations containing the RNI for thiamine: 1.4 mg/d for pregnant/lactating women (from 12-16 weeks pregnancy through 6 months postnatal), and 0.5 mg/d for children (6-18 months postnatal)
High-thiamine MMS
EXPERIMENTALmultiple micronutrient supplement formulations containing a higher dose of daily thiamine: 10 mg/d for pregnant/lactating women (12-16 weeks pregnancy through 6 months postnatal), and 5 mg/d for children (6-18 months postnatal)
Interventions
Standard of Care+ group From 12-16 weeks gestation through to 6 months postnatal, women will consume tablets orally. Starting at 6 months postnatal, supplements will then be administered directly to infants as daily liquid supplement drops. Details of supplement contents are found in the full protocol. Multiple micronutrient supplements will include the standard 15 micronutrients included in the United Nations International Multiple Micronutrient Antenatal Preparation Multiple Micronutrient Supplements (UNIMAPP MMS) formulation, which are the same found in standard micronutrient powders designed for children 6-24 months: thiamine, as well as vitamins A, D, E, K, C, B2, B3, B6, B12, folic acid, iodine, zinc, selenium, and copper. "Standard of Care +" and "High thiamine MMS" groups will take supplements that are identical except for thiamine content. Women: 1.4 mg thiamine Children: 0.5 mg thiamine
Eligibility Criteria
You may qualify if:
- women aged 18-45 years
- (+0) to 15(+6) weeks pregnant, based on last menstrual period
- planning to breastfeed for at least 6 months
You may not qualify if:
- consumed thiamine-containing supplements in the preceding 3 months
- planning on moving out of province in the next year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mount Saint Vincent Universitylead
- University of Oregoncollaborator
- Flinders Universitycollaborator
- Helen Keller Internationalcollaborator
- Institut de Recherche pour le Développement (IRD)collaborator
- Weiss Asset Management Foundationcollaborator
- Factors Group of Nutritional Companies Inc.collaborator
- NCHADS - Ministry of Health of Cambodiacollaborator
Study Sites (1)
Community-based study
Kampong Thom, Cambodia
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Department of Applied Human Nutrition
Study Record Dates
First Submitted
August 19, 2026
First Posted
August 31, 2026
Study Start
June 1, 2026
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
March 31, 2029
Last Updated
August 31, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will share
Data will be stored in a repository, and will be made available upon request pending application and approval of the PI.